EXICURE, INC.
XCURNasdaq
$1.68
↑ +3.7%Jul 17 close · end-of-day
Price
1Y↓ -74.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$10.7M
Enterprise Value
$10.7M
P/E
—
P/S
—
P/B
5.1
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$0.00
Net Income (TTM)
-$9.8M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-466.4%
ROIC
-331.2%
Debt / Equity
—
Net Cash
—
Return 1Y
-78.2%
Company profile
Exicure, Inc. develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders.
- CEO
- Matthias G. Schroff
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 50
- Headquarters
- Illinois
- Website
- exicuretx.com
Earnings
XCUR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$0.00—
Diluted EPS-$0.29↓ -159.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $16.6M | -$483,000.00 | $28.8M | $0.00 | $500,000.00 | $0.00 |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$25.4M | -$62.5M | -$1.8M | -$15.0M | -$12.2M | -$4.2M |
| Net income | -$24.7M | -$64.1M | -$2.6M | -$16.9M | -$9.7M | -$4.9M |
| Diluted EPS | -$0.28 | -$21.70 | -$0.56 | -$10.55 | -$4.75 | -$0.79 |
| Operating cash flow | -$39.3M | -$34.8M | -$35.7M | -$10.4M | -$2.9M | -$8.6M |
| Free cash flow | -$42.4M | -$35.8M | -$35.7M | -$10.4M | -$2.9M | -$8.6M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -153.1% | 12950.1% | -6.4% | — | -2446.4% | — |
| Net margin | -148.5% | 13271.6% | -9.0% | — | -1940.2% | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.2M | -$2.6M | -$7.6M | $2.9M | -$2.5M | -$2.4M | -$2.3M | -$1.6M |
| Net income | -$600,000.00 | -$1.1M | -$7.2M | $3.0M | -$2.6M | -$2.4M | -$2.9M | -$1.8M |
| Diluted EPS | -$0.35 | -$0.57 | -$3.35 | $0.49 | -$0.41 | -$0.39 | -$0.48 | -$0.29 |
| Operating cash flow | -$1.2M | -$449,000.00 | -$845,000.00 | -$1.6M | -$2.3M | -$3.5M | -$1.1M | -$1.1M |
| Free cash flow | — | -$449,000.00 | — | — | — | -$3.6M | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Apr 22, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-08 | HiTron Systems Inc. | J | 117,441 | $4.50 | $528,484.50 | filing |
| 2026-06-26 | HiTron Systems Inc. | J | 253,195 | $4.50 | $1.1M | filing |
| 2026-06-24 | HiTron Systems Inc. | J | 123,456 | $4.50 | $555,552.00 | filing |
| 2026-06-23 | HiTron Systems Inc. | J | 129,183 | $4.50 | $581,323.50 | filing |
| 2026-02-16 | Miller Josh· Chief Accounting Officer | Tax withholding | 8 | $4.08 | $32.64 | filing |
| 2026-01-21 | HiTron Systems Inc. | Sale | 258,367 | $4.50 | $1.2M | filing |
| 2026-01-16 | HiTron Systems Inc. | Sale | 734,747 | $4.50 | $3.3M | filing |
| 2026-01-07 | HiTron Systems Inc. | Sale | 741,272 | $4.50 | $3.3M | filing |
| 2025-12-08 | SANGSANGIN INVESTMENT & SECURITIES CO., LTD. | Sale | 433,332 | $8.71 | $3.8M | filing |
| 2025-11-16 | Miller Josh· Chief Accounting Officer | Tax withholding | 7 | $3.71 | $25.97 | filing |
| 2025-08-16 | Miller Josh· Chief Accounting Officer | Tax withholding | 9 | $6.65 | $59.85 | filing |
Latest 11 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.